NEW YORK, March 13, 2018 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Obalon Therapeutics, Inc. (NASDAQ:OBLN) from October 5, 2016 through January 23, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Obalon investors under the federal securities laws.
To join the Obalon class action, go to http://rosenlegal.com/cases-1275.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, during the Class Period defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Obalon recognized revenue in violation of Generally Accepted Accounting Principles; (2) Obalon lacked adequate internal controls over accounting and financial reporting; and (3) as a result, defendants’ statements about Obalon’s business, operations, and prospects were materially false and misleading at all relevant times.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 16, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1275.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Jetstar to Charge for Overhead Cabin Bags From February
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 



